Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery

Clinical trial NCT00913120 · COMPLETED

Trial details

NCT number: NCT00913120
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Venous Thromboembolism

Start date: 2009-05-01
Primary completion: 2010-03-01
Enrollment: 610

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.